| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/31/2006 | EP1660044A2 Composition comprising a zeolite compound for treatment of diseases |
| 05/31/2006 | EP1660036A2 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production |
| 05/31/2006 | EP1660026A2 Treatment for cd5+ b cell lymphoma |
| 05/31/2006 | EP1346226B1 Screening method based on siah-numb interaction |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1333845A4 Treatment of t cell disorders |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1315500A4 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | EP1272156B1 Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials |
| 05/31/2006 | EP1263467B1 Paste formulations comprising silica |
| 05/31/2006 | EP1246789B1 Methods of making optically pure (r)- and (s)- didesmethylsibutramine |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1165073B1 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP1121109B1 Biphasic tramadol preparation |
| 05/31/2006 | EP1112067B1 Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | EP0861321B1 Phosphopantetheinyl transferases and uses thereof |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | CN1780642A Remedy for diabetes |
| 05/31/2006 | CN1780629A Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics |
| 05/31/2006 | CN1780628A Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid |
| 05/31/2006 | CN1780627A Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 05/31/2006 | CN1780620A Use of a topical medicament comprising riluzole |
| 05/31/2006 | CN1780616A Selective cytokine inhibitory drugs for treating disorders of the central nervous system. |
| 05/31/2006 | CN1780610A Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances |
| 05/31/2006 | CN1780606A Fibrate tablet and method for the production thereof |
| 05/31/2006 | CN1778391A Safety and high-efficient compound hypolipidemic medicine |
| 05/31/2006 | CN1778390A Production of aerosol containing biological activity |
| 05/31/2006 | CN1778296A Long-acting preparation for tatin medicine |
| 05/30/2006 | US7053183 Human cyclic nucleotide-gated cation channel polypeptide |
| 05/30/2006 | US7053176 Combination of C1-INH and lung surfactant for the treatment of respiratory disorders |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053092 Therapy for nervous system disorders; psychological disorders |
| 05/30/2006 | US7053080 A mixture comprising an aryl 2-azetidinone derivatives, and other active drug for preventing obesity, and antichlesterol agents, for lowering a steroid concentration in plasma; synergistic improve method; monoamine oxidase inhibitors |
| 05/30/2006 | US7053065 Vitamin B12 and pemetrexed disodium combination therapies |
| 05/30/2006 | US7053050 administering erythropoietin receptor antagonist or mimetics thereof |
| 05/30/2006 | US7053049 Cardiovascular disorders; anticholesterol agents; administering apolipoproteins and phospholipids mixture |
| 05/30/2006 | US7053045 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 05/30/2006 | US7052900 Saccharomyces cerevisiae yeast strain with functional expression of a Glut transporter |
| 05/30/2006 | US7052895 nucleotide sequences that code amino acid sequences having hydrolase enzyme activity, used for medical diagnosis, for prophylaxis of diseases and drug screening; bioassay |
| 05/30/2006 | US7052850 Isolated human EDG-4 receptor |
| 05/30/2006 | US7052832 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 05/30/2006 | US7052690 by isolating a mammalian conjunctival tissue explant in a growth medium until nodules form, then allowing cells to grow; for treating lacerated corneas, ocular cicatricial pemphigoid, Steven Johnson syndrome, alkali burns and neurotrophic keratitis; kits for detecting mucin deficiency |
| 05/30/2006 | US7052688 At least one strain of hydrogen peroxide-producing lactic acid bacteria, and at least one strain of arginine-utilizing lactic acid bacteria; treatment of infections and inflammatory conditions caused by bacteria, viruses, fungi |
| 05/30/2006 | US7052685 Methods for treatment of cutaneous T-cell lymphoma |
| 05/30/2006 | US7052684 Methods of healing wounds and fibrotic disorders using IL-10 |
| 05/30/2006 | US7052680 aerosols containing antiparkinsons drugs benzotropine, pergolide, amantadine, deprenyl and ropinerole, that have been heated on a solid support such as foil and condensed by passing through a flow of air |
| 05/30/2006 | US7052679 thin film of drugs; heating; dispensing as aerosol condensation |
| 05/30/2006 | CA2375908C Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/30/2006 | CA2288970C Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 05/30/2006 | CA2264718C Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| 05/30/2006 | CA2237594C Fused imidazole derivatives as multidrug resistance modulators |
| 05/30/2006 | CA2200220C Drug for tumor growth suppression |
| 05/26/2006 | WO2006055747A2 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 05/26/2006 | WO2006055743A2 Compbination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs |
| 05/26/2006 | WO2006055659A2 Fixed dose combination op dutasteride and tamsulosin |
| 05/26/2006 | WO2006054773A1 Activation of caspase in the cell division stage of cancer cells and utilization of caspase inhibitor in anticancer agent and so on |
| 05/26/2006 | WO2006054770A1 Novel map kinase kinase kinase (mapkkk) |
| 05/26/2006 | WO2006054748A1 Remedy for nephritis |
| 05/26/2006 | WO2006054691A1 Soluble protein and utilization of the same |
| 05/26/2006 | WO2006054652A1 Amide compound |
| 05/26/2006 | WO2006054629A1 1-SUBSTITUTED-3-β-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME |
| 05/26/2006 | WO2006054514A1 Preventive or therapeutic pharmaceutical composition for neuropathic pain |
| 05/26/2006 | WO2006054513A1 Preventive or therapeutic agent for neuropathic pain |
| 05/26/2006 | WO2006054294A1 Composition and method for potentiating drugs |
| 05/26/2006 | WO2006054281A1 Compositions containing beta 2-glycoprotein i for the prevention and/or treatment of vascular disease |
| 05/26/2006 | WO2006053884A1 Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
| 05/26/2006 | WO2006027052A3 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 05/26/2006 | WO2006005415A3 Use of l-carnitine and glucose for the treatment of cardiovascular diseases |
| 05/26/2006 | WO2005115471A3 Methods and compositions for treatment of nicotine dependence and dementias |
| 05/26/2006 | WO2005110438A3 Methods and products related to the intracellular delivery of polysaccharides |
| 05/26/2006 | WO2005080338A3 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins |
| 05/26/2006 | WO2005075022A3 Susceptibility gene for myocardial infraction, stroke, and paod; methods of treatment |
| 05/26/2006 | WO2005046796A3 Combinations of a cholesterol biosynthesis inhibitor and a soluble fiber for the treatment of conditions associated with elevated cholesterol levels |
| 05/26/2006 | WO2005030933A3 Bone morphogenetic protein (bmp)-7 based diagnosis and treatment of cancer |
| 05/26/2006 | WO2005018677A3 Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer |
| 05/26/2006 | WO2003100007A3 Eta-1 gene and methods for use |
| 05/26/2006 | CA2589001A1 Preventive or therapeutic agent for neuropathic pain |
| 05/26/2006 | CA2588963A1 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 05/26/2006 | CA2587658A1 Antibiotic compounds, compositions and medical uses |
| 05/26/2006 | CA2587598A1 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 05/26/2006 | CA2585317A1 Drug combination for the treatment of depression and related disorders comprising a selective serotonin reuptake inhibitor |
| 05/26/2006 | CA2584619A1 Amide compound |
| 05/25/2006 | US20060111607 Cardiac support with metallic structure |
| 05/25/2006 | US20060111585 Title of the invention n-cyclohexylaminocarbonyl benzensulfonmide derivatives |
| 05/25/2006 | US20060111407 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111366 Pharmaceutical use of substituted amides |
| 05/25/2006 | US20060111365 Combinations comprising N- {5-[4- [4-methy L-piperazino-methyl) -benzoylamido] -2-methylphenyl) -4- (3-pyridyl) -2-pyrimidine-amine and at least one telomerase inhibitor |
| 05/25/2006 | US20060111358 Treatment of aml |